Ilan Kedan, MD
Opted out of Medicare from March 2024 to March 2028. Internal Medicine, Interventional Cardiology (MD) in Beverly Hills, California, licensed in CA and DC, with an NPI issued in May 2006. Their prescriptions cost Medicare Part D more than their services did: $563,050 for 3,068 claims, against $30,546 paid for services in 2024. Amgen Inc. was the largest of 11 companies reporting payments in 2025, $708.84 in all, mostly food and beverage.
Overview
| NPI | 1689629057 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | May 24, 2006 |
| Last updated in NPPES | Feb 27, 2025 |
| Certified by provider | Feb 27, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Interventional Cardiology Primary | 207RI0011X | A93684 | CA |
| Specialist | 174400000X | A93684 | CA |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | MD034206 | DC |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Mar 15, 2024 – Mar 15, 2028 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 238 |
|---|---|
| Services billed | 450 across 25 procedure codes |
| Paid by Medicare | $30,546 |
Part D prescriptions in 2024
| Prescriptions (claims) | 3,068 · 7,123 30-day fills |
|---|---|
| Patients | 496 |
| Total drug cost | $563,050 |
| Generic share | 82% of claims |
Industry payments (Open Payments)
- 2025$708.84 · 28 payments from 11 companies
- 2024$581.44 · 25 payments from 14 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Amgen Inc. | $155.15 | 7 |
| Madrigal Pharmaceuticals | $92.20 | 3 |
| Abbvie Inc. | $83.67 | 3 |
| Novo Nordisk Inc | $80.29 | 3 |
| Alnylam Pharmaceuticals Inc. | $76.70 | 3 |
What the 2025 payments were for
- Food and Beverage$708.84 · 28 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Interventional Cardiology providers in Beverly Hills
- 1730151085
- 1033263272
- 1356635478
- 1992879399
- 1972762912
All Internal Medicine, Interventional Cardiology providers in California →